Ko-Med Centra Kliniczne Sp. z o.o.

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Stroke4 trials
• Atrial fibrillation3 trials
• Coronary artery disease1 trial
• Psoriasis1 trial

Phase

• Phase 34 trials
• Phase 21 trial

Status

• Completed3 trials
• Not yet recruiting1 trial
• Terminated1 trial

Lead sponsor

• Regeneron Pharmaceuticals2 trials
• Amgen1 trial
• Arctic Bioscience AS1 trial
• Bayer AG1 trial

Running trials

• Recruiting

  Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  NCT07626411· Phase 3· Regeneron Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation1 recruiting
• Stroke1 recruiting

Closed trials

• Recruiting

  Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

  NCT07430956· Phase 3· Regeneron Pharmaceuticals· Source

• Completed

  An efficacy and safety study of HRO350 in patients with mild-to-moderate psoriasis (the ‘HeROPA’ study)

  2022-501850-12-00· Phase 2· Arctic Bioscience AS· Source

• Completed

  A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolism in people with irregular and often rapid heartbeat (atrial fibrillation), and at risk for stroke

  NCT05643573· Phase 3· Bayer AG· Source

• Completed

  Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

  NCT03872401· Phase 3· Amgen· Source